Search results for abx831273

Bimagrumab, Abbexa, abx831273

Bimagrumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ACVR2A/ACVR2B, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Bimagrumab has been used in trials studying the treatment and supportive care of Sarcopenia, Skeletal Muscle, Mechanical Ventilation, Sporadic Inclusion Body Myositis, and Sporadic Inclusion Body Myositis (sIBM), among others.